Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

The NHS and pharma: Let’s work together

August 13, 2007 Research and Development, Sales and Marketing NHS, healthcare, industry relations, joint working, pharma

In the last 10 years, pharma’s relationship with the NHS has undergone a transformation. For one thing, it’s difficult now …
Feature

Close encounters with the NHS

August 6, 2007 Research and Development, Sales and Marketing NHS, healthcare, industry relations, pharma

Most marketers in the pharma industry understand the need to get alongside and talk to key people in the NHS …
Feature

ReNeuron acquires Californian base and new diabetes technology

August 2, 2007 Research and Development

Pioneering British stem cell research company ReNeuron has bought the Californian company, AmCyte – a move it hopes will make …
News

Latest news from Datamonitor

July 27, 2007 Research and Development, Sales and Marketing

BioMS's multiple sclerosis trial gets positive reviewBioMS Medical's relapsing-remitting multiple sclerosis trial has received a positive review from the data …
News

Lilly expands UK research lab

July 23, 2007 Research and Development

Lilly has opened a new extension to its UK drug research laboratories which specialise in new medicines for neurological conditions.The …
News

Latest news from Datamonitor

July 23, 2007 Research and Development, Sales and Marketing

Affiris begins clinical testing of Alzheimer's vaccineAffiris' Alzheimer's vaccine Affitope has now entered the clinical phase of its development and …
News

Latest news from Datamonitor

July 16, 2007 Research and Development, Sales and Marketing

Antisoma drops ovarian cancer drugCancer drug developer Antisoma says new data from its Phase II trial of ASA404 showed that …
News

Time is money in R&D

July 16, 2007 Research and Development clincial trials, drug development, productivity

There is a much-quoted statistic, which has become so hackneyed that it's largely ignored these days, but while you are …
Feature

Piramed and Domainex named among best of British biotech

July 12, 2007 Research and Development Piramed, domainex

Piramed and Domainex are among the cutting-edge companies which have been recognised as the best of the UKs biotech sector.UK …
News

Latest news from Datamonitor

July 9, 2007 Research and Development, Sales and Marketing

Genzyme says osteoarthritis treatment misses trial goalsGenzyme has reported that its trial of hylastan in treating pain in patients with …
News

Latest news from Datamonitor

July 2, 2007 Research and Development

Biovest reports encouraging interim results for cancer vaccineBiovest International, a majority-owned subsidiary of Accentia Biopharmaceuticals, has revealed positive interim data …
News

Clinical Trials: The future is hub-shaped

July 2, 2007 Research and Development clinical trials, design

The global clinical trials market continues to grow and is currently worth an estimated $10 billion; so much so that …
Feature

Roche strengthens autoimmune franchise with arthritis drug deal

June 28, 2007 Research and Development, Sales and Marketing

Roche has added a novel treatment for rheumatoid arthritis to its early stage pipeline, one it says has the potential …
News

Latest news from Datamonitor

June 22, 2007 Research and Development, Sales and Marketing NSCLC, Novartis, Pfizer

 Novartis receives FDA approval for blood pressure medicineNovartis has been granted final FDA approval for Exforge, its high blood pressure …
News

GSK commits milions of pounds to new imaging centre

June 21, 2007 Research and Development

The largest new imaging centre in Europe – an £83 million collaboration between GlaxoSmithKline (GSK), Imperial College London and the …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026